Brief: Sangamo Therapeutics Q4 EPS USD -0.11
30/03/2026 21:01
Mar 30 (Reuters) - Sangamo Therapeutics Q4 operating income USD -38.203 million. Q4 revenue USD 14.228 million Q4 net income USD -37.419 million Q4 operating expenses USD 52.4 million Q4 adjusted operating expenses USD 36 million